Recombinant arginine-degrading enzymes in metabolic anticancer therapy and bioanalytics. (Q38250898)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231409 AND SRC:MED&resulttype=core&format=json

16 February 2020

review article

1 reference

title

Recombinant arginine-degrading enzymes in metabolic anticancer therapy and bioanalytics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231409 AND SRC:MED&resulttype=core&format=json

16 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231409 AND SRC:MED&resulttype=core&format=json

16 February 2020

Yuriy R. Boretsky

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231409 AND SRC:MED&resulttype=core&format=json

16 February 2020

Andriy Sibirny

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231409 AND SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Mykhailo V Gonchar

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231409 AND SRC:MED&resulttype=core&format=json

16 February 2020

publication date

3 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231409 AND SRC:MED&resulttype=core&format=json

Cell Biology International

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231409 AND SRC:MED&resulttype=core&format=json

16 February 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231409 AND SRC:MED&resulttype=core&format=json

16 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231409 AND SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

246-252

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231409 AND SRC:MED&resulttype=core&format=json

Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging

16 February 2020

cites work

1 reference

Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes.

21 January 2018

1 reference

Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis.

21 January 2018

1 reference

ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance

21 January 2018

1 reference

Improved method for expression and isolation of the Mycoplasma hominis arginine deiminase from the recombinant strain of Escherichia coli.

21 January 2018

1 reference

Arginine deprivation as a targeted therapy for cancer

21 January 2018

1 reference

Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis

21 January 2018

1 reference

Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes

21 January 2018

1 reference

High-level expression of Mycoplasma arginine deiminase in Escherichia coli and its efficient renaturation as an anti-tumor enzyme

21 January 2018

1 reference

Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges

21 January 2018

1 reference

Agmatine: clinical applications after 100 years in translation.

21 January 2018

1 reference

Single amino acid arginine deprivation triggers prosurvival autophagic response in ovarian carcinoma SKOV3

21 January 2018

1 reference

Replacing Mn(2 ) with Co(2 ) in human arginase i enhances cytotoxicity toward l-arginine auxotrophic cancer cell lines.

21 January 2018

1 reference

Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy

21 January 2018

1 reference

Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (H

21 January 2018

1 reference

Canavanine augments proapoptotic effects of arginine deprivation in cultured human cancer cells

21 January 2018

1 reference

Single amino acid arginine starvation efficiently sensitizes cancer cells to canavanine treatment and irradiation

21 January 2018

1 reference

Three-dimensional environment renders cancer cells profoundly less susceptible to a single amino acid starvation

21 January 2018

1 reference

Controlling cancer by restricting arginine availability--arginine-catabolizing enzymes as anticancer agents

21 January 2018

1 reference

Integrity and stability of the citrulline-arginine pathway in normal and tumour cell lines

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/CBIN.10383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25231409 AND SRC:MED&resulttype=core&format=json

16 February 2020

1 reference